In vitro stimulation of HIV specific CD8+ T cells

HIV 特异性 CD8 T 细胞的体外刺激

基本信息

  • 批准号:
    7073861
  • 负责人:
  • 金额:
    $ 37.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1999
  • 资助国家:
    美国
  • 起止时间:
    1999-03-15 至 2006-06-14
  • 项目状态:
    已结题

项目摘要

Although cytotoxic CD8+ T cells (CTL) play an important protective role during HIV infection, a number of studies have revealed that these important cells may suffer from functional defects that impair their efficiency in controlling HIV virus. Studies from our laboratory have revealed that HIV-specific CD8+ T cells exhibit increased susceptibility to apoptosis. We have shown that HIV-specific CD8+ T cells are very sensitive to CD95/Fas-induced apoptosis and that HIV-infected macrophages can kill HIV-specific CD8+ T cells by a CD95/Fas-dependent mechanism. In addition, HIV-specific CD8+ T cells lack terminal differentiation and CD95/Fas apoptosis may be involved in this skewing of differentiation. The ability of HIV-specific CD8+ T cells therefore to kill infected cells and their differentiation may be compromised due to CD95/Fas-mediated apoptosis of these cells. Recently, we have found a decrease in the anti-apoptotic molecules Bcl-2 and Bcl-XL in HIV-specific CD8+ T cells, suggesting that this may account at least partially for the increased apoptosis sensitivity. Based on our findings from in vitro studies of HIV-specific CD8+ T cells we hypothesize that HIV-specific CD8+ T cells are in a proapoptotic state due to an imbalance of pro- and anti-apoptotic factors and that this is the result of priming in the absence of HIV-specific CD4+ T cell help, chronic stimulation or a combination of both. This chronic stimulation, aberrant priming or both, results in increased apoptotic potential and defective proliferative capacity. In the current proposal we will investigate the molecular mechanism(s) involved in the increased apoptosis sensitivity of HIV-specific CD8+ T cells. We will also determine the in vivo mechanisms in mice that result in virus-specific CD8+ T cells that exhibit increased apoptosis sensitivity, functional defects and molecular profiles similar to HIV-specific CD8+ T cells. Understanding the mechanism behind these defects of HIV-specific CD8+ T cells may allow for the restoration of survival or function of HIV-specific CD8+ T cells which in turn would have a profound effect in controlling or clearing HIV. Finally, such an understanding will be critical for the development of vaccines that provide long lasting CTL immunity.
尽管细胞毒性CD8+T细胞(CTL)在HIV感染过程中起着重要的保护作用,但许多研究表明,这些重要细胞可能存在功能缺陷,从而影响其控制HIV病毒的效率。我们实验室的研究表明,HIV特异性CD8+T细胞对凋亡的敏感性增加。我们发现HIV特异性CD8+T细胞对CD95/Fas诱导的细胞凋亡非常敏感,HIV感染的巨噬细胞可以通过CD95/Fas依赖的机制杀伤HIV特异性CD8+T细胞。此外,HIV特异性CD8+T细胞缺乏终末分化,CD95/Fas的凋亡可能参与了这种分化的倾斜。HIV特异性CD8+T细胞的功能 因此,CD95/Fas介导的细胞凋亡可能会影响细胞对感染细胞的杀伤和分化。最近,我们发现HIV特异性CD8+T细胞中抗凋亡分子Bcl2和Bclxl的表达减少,提示这可能是导致细胞凋亡敏感性增加的至少部分原因。根据我们对HIV特异性CD8+T细胞的体外研究结果,我们假设HIV特异性CD8+T细胞由于促凋亡和抗凋亡因子的失衡而处于促凋亡状态,这是在缺乏HIV特异性CD4+T细胞帮助、慢性刺激或 两者兼而有之。这种慢性刺激、异常启动或两者兼而有之,会导致细胞凋亡潜能增加和增殖能力受损。在目前的方案中,我们将探讨HIV特异性CD8+T细胞凋亡敏感性增加的分子机制(S)。我们还将在小鼠身上确定导致病毒特异性CD8+T细胞的体内机制,这些细胞表现出更高的凋亡敏感性、功能缺陷和类似于HIV特异性CD8+T细胞的分子特征。了解HIV特异性CD8+T细胞这些缺陷背后的机制可能有助于恢复HIV特异性CD8+T细胞的存活或功能,这反过来将对控制或清除HIV产生深远的影响。最后,这样的理解对于开发提供持久CTL免疫的疫苗至关重要。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

PETER D KATSIKIS其他文献

PETER D KATSIKIS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('PETER D KATSIKIS', 18)}}的其他基金

Phosphorothioate Oligonucleotides as Microbicides against HIV Transmission
硫代磷酸酯寡核苷酸作为抗 HIV 传播的杀菌剂
  • 批准号:
    8516438
  • 财政年份:
    2010
  • 资助金额:
    $ 37.5万
  • 项目类别:
Phosphorothioate Oligonucleotides as Microbicides against HIV Transmission
硫代磷酸酯寡核苷酸作为抗 HIV 传播的杀菌剂
  • 批准号:
    8695278
  • 财政年份:
    2010
  • 资助金额:
    $ 37.5万
  • 项目类别:
Phosphorothioate Oligonucleotides as Microbicides against HIV Transmission
硫代磷酸酯寡核苷酸作为抗 HIV 传播的杀菌剂
  • 批准号:
    8062112
  • 财政年份:
    2010
  • 资助金额:
    $ 37.5万
  • 项目类别:
Phosphorothioate Oligonucleotides as Microbicides against HIV Transmission
硫代磷酸酯寡核苷酸作为抗 HIV 传播的杀菌剂
  • 批准号:
    7884776
  • 财政年份:
    2010
  • 资助金额:
    $ 37.5万
  • 项目类别:
Phosphorothioate Oligonucleotides as Microbicides against HIV Transmission
硫代磷酸酯寡核苷酸作为抗 HIV 传播的杀菌剂
  • 批准号:
    8482137
  • 财政年份:
    2010
  • 资助金额:
    $ 37.5万
  • 项目类别:
Dendritic cell regulation of CD8+ T cell responses
CD8 T 细胞反应的树突状细胞调节
  • 批准号:
    6964213
  • 财政年份:
    2005
  • 资助金额:
    $ 37.5万
  • 项目类别:
Dendritic cell regulation of CD8+ T cell responses
CD8 T 细胞反应的树突状细胞调节
  • 批准号:
    7084539
  • 财政年份:
    2005
  • 资助金额:
    $ 37.5万
  • 项目类别:
Dendritic cell regulation of CD8+ T cell responses
CD8 T 细胞反应的树突状细胞调节
  • 批准号:
    7386756
  • 财政年份:
    2005
  • 资助金额:
    $ 37.5万
  • 项目类别:
Dendritic cell regulation of CD8+ T cell responses
CD8 T 细胞反应的树突状细胞调节
  • 批准号:
    7211374
  • 财政年份:
    2005
  • 资助金额:
    $ 37.5万
  • 项目类别:
Dendritic cell regulation of CD8+ T cell responses
CD8 T 细胞反应的树突状细胞调节
  • 批准号:
    7587430
  • 财政年份:
    2005
  • 资助金额:
    $ 37.5万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了